Axicabtagene ciloleucelCytokine release syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1740卷 / 1期

关键词：

D O I：

10.1007/s40278-019-57947-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：54 / 54

相关论文

共 50 条

[31] Antipsychotics/axicabtagene-ciloleucel/bupropionCytokine release syndrome, neurotoxicity and neutropenia: case report
Reactions Weekly, 2021, 1847 (1) : 71 - 71
[32] Axicabtagene-ciloleucel/tocilizumabCytokine release syndrome and immune effector cell-associated neurotoxicity syndrome : case report
Reactions Weekly, 2022, 1921 (1) : 55 - 55
[33] Axicabtagene-ciloleucel/tisagenlecleucelCytokine release syndrome and neurotoxicity syndrome: 20 case reports
Reactions Weekly, 2020, 1823 (1) : 86 - 86
[34] Axicabtagene-ciloleucel/tocilizumabCytokine release syndrome and neurotoxicity: 3 case reports
Reactions Weekly, 2021, 1854 (1) : 72 - 72
[35] Axicabtagene-ciloleucel/tisagenlecleucelCytokine release syndrome
Reactions Weekly, 2024, 1989 (1) : 39 - 39
[36] Axicabtagene ciloleucelNeurotoxicity: case report
Reactions Weekly, 2022, 1892 (1) : 51 - 51
[37] Axicabtagene-ciloleucel/DexamethasoneCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: case report
Reactions Weekly, 2024, 2025 (1) : 64 - 64
[38] Axicabtagene ciloleucelGrade 2 cytokine release syndrome
Reactions Weekly, 2024, 2016 (1) : 77 - 77
[39] Axicabtagene-ciloleucel/dexamethasone Immune effector cell-associated neurotoxicity syndrome, cytokine release syndrome and lack of efficacy: case report
Reactions Weekly, 2023, 1960 (1) : 82 - 82
[40] Axicabtagene-ciloleucel/dexamethasone/tocilizumabCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: case report
Reactions Weekly, 2023, 1940 (1) : 91 - 91

← 1 2 3 4 5 →